College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
Int J Oncol. 2018 Dec;53(6):2356-2368. doi: 10.3892/ijo.2018.4578. Epub 2018 Sep 28.
Ganoderma lucidum polysaccharides (GLP) has been demonstrated to elicit antitumorigenic and proapoptotic activities in cancer; however, the molecular mechanisms underlying the anticancer effects of GLP have yet to be elucidated. Non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) has been reported to exert proapoptotic effects and therefore, may serve an important role in cancer prevention. The present study aimed to elucidate the molecular mechanism by which GLP stimulates anticancer activity in human prostate cancer (PCa) PC-3 cells. In addition, the role of NAG-1 in GLP-induced cancer inhibition was examined. The results of the present study demonstrated that GLP significantly inhibited cell viability in a time- and dose-dependent manner in PC-3 cells. Flow cytometry indicated that GLP induced late apoptosis, which was accompanied by poly (ADP-ribose) polymerase 1 (PARP) cleavage, and inhibition of pro-caspase-3, -6 and -9 protein expression. Furthermore, it was observed that the expression levels of NAG-1, and its transcriptional factor early growth response-1, were upregulated in a time- and dose-dependent manner upon GLP treatment. The results of a luciferase assay demonstrated that GLP induced the promoter activity of NAG-1, thus indicating that NAG-1 may be transcriptionally regulated by GLP. The secretion of NAG-1 proteins into the cell culture medium was also upregulated upon GLP treatment. Furthermore, inhibition of NAG-1 expression by small interfering RNA significantly, but not completely, prevented GLP-induced apoptosis, and reversed the effects of GLP on PARP and pro-caspase expression. It was further demonstrated that GLP inhibited the phosphorylation of protein kinase B and mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in PC-3 cells. The present study is the first, to the best of our knowledge, to report that GLP may induce apoptosis of PCa cells, which is partially mediated through NAG-1 induction. The present findings may be helpful in elucidating the anticancer mechanisms of GLP through NAG-1 induction for its chemopreventive potential in PCa.
灵芝多糖 (GLP) 已被证明具有抗肿瘤和促凋亡活性;然而,GLP 抗癌作用的分子机制尚未阐明。非甾体抗炎药激活基因-1 (NAG-1) 已被报道具有促凋亡作用,因此可能在癌症预防中发挥重要作用。本研究旨在阐明 GLP 刺激人前列腺癌 (PCa) PC-3 细胞抗癌活性的分子机制。此外,还研究了 NAG-1 在 GLP 诱导的癌症抑制中的作用。本研究结果表明,GLP 可显著抑制 PC-3 细胞的细胞活力,呈时间和剂量依赖性。流式细胞术表明,GLP 诱导晚期凋亡,同时伴有多聚 (ADP-核糖) 聚合酶 1 (PARP) 裂解,以及抑制原半胱天冬酶-3、-6 和-9 蛋白表达。此外,还观察到 GLP 处理后 NAG-1 及其转录因子早期生长反应-1 的表达水平呈时间和剂量依赖性上调。荧光素酶测定结果表明,GLP 诱导 NAG-1 启动子活性,表明 NAG-1 可能受 GLP 的转录调控。GLP 处理后,NAG-1 蛋白分泌到细胞培养液中的水平也上调。此外,用小干扰 RNA 抑制 NAG-1 表达可显著但不完全阻止 GLP 诱导的细胞凋亡,并逆转 GLP 对 PARP 和原半胱天冬酶表达的影响。进一步证实 GLP 抑制了 PC-3 细胞蛋白激酶 B 和丝裂原活化蛋白激酶/细胞外信号调节激酶信号的磷酸化。本研究首次报道 GLP 可能通过诱导 NAG-1 诱导诱导 PCa 细胞凋亡,部分通过 NAG-1 诱导来实现。本研究结果可能有助于通过 NAG-1 诱导阐明 GLP 的抗癌机制,为其在前列腺癌中的化学预防潜力提供依据。